788 filings
Page 8 of 40
6-K
qk73ity02qjh 1ih4
19 Mar 21
Current report (foreign)
12:00am
6-K
0j2i9la95p
16 Mar 21
Current report (foreign)
1:15pm
6-K
piwyyv
11 Mar 21
Announces the Initiation of Its Preclinical Program for the Potential
8:30am
6-K
ob21hvml1
9 Mar 21
Current report (foreign)
7:00am
6-K
7ffbxg
18 Feb 21
Current report (foreign)
4:05pm
424B5
vxcm8z1p 3hoqdx45i3
18 Feb 21
Prospectus supplement for primary offering
8:00am
FWP
sibppt llo
17 Feb 21
Free writing prospectus
6:02am
FWP
gdrehyw0 tkleandid
17 Feb 21
Free writing prospectus
6:01am
F-3MEF
3xo64i3 92g9lbq
16 Feb 21
Registration statement to add securities to prior F-3 registration
8:09pm
FWP
xyk 2900fh8fa
16 Feb 21
Free writing prospectus
5:18pm
424B5
ecglttgyoxy52b0e6akk
16 Feb 21
Prospectus supplement for primary offering
5:00pm
6-K
yd1grj
2 Feb 21
Current report (foreign)
7:40am
6-K
gnjcys7q2en3oh8o21as
28 Jan 21
Aeterna Zentaris Expands Orphan Drug Development Pipeline with Targeted Immunosuppressive Therapeutics
4:05pm
6-K
2v6gto
26 Jan 21
Aeterna Zentaris Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
5:30pm
6-K
fbjhd8bsf9zi7c8r8mab
7 Dec 20
Current report (foreign)
8:15am
6-K
xue89dqpzo zhq8z5
16 Nov 20
Current report (foreign)
8:15am
424B3
gu34c6 cv8bk8b9o
13 Nov 20
Prospectus supplement
4:45pm
424B3
8hp9nwu05o
13 Nov 20
Prospectus supplement
4:45pm
6-K
ozmstd98wl
5 Nov 20
Condensed Interim Consolidated Financial Statements
4:32pm
424B3
pqza t2f99pwj
21 Oct 20
Prospectus supplement
4:30pm